6l48 Citations

Structural insights into the inhibition mechanism of human sterol O-acyltransferase 1 by a competitive inhibitor.

OpenAccess logo Nat Commun 11 2478 (2020)
Cited: 36 times
EuropePMC logo PMID: 32424158

Abstract

Sterol O-acyltransferase 1 (SOAT1) is an endoplasmic reticulum (ER) resident, multi-transmembrane enzyme that belongs to the membrane-bound O-acyltransferase (MBOAT) family. It catalyzes the esterification of cholesterol to generate cholesteryl esters for cholesterol storage. SOAT1 is a target to treat several human diseases. However, its structure and mechanism remain elusive since its discovery. Here, we report the structure of human SOAT1 (hSOAT1) determined by cryo-EM. hSOAT1 is a tetramer consisted of a dimer of dimer. The structure of hSOAT1 dimer at 3.5 Å resolution reveals that a small molecule inhibitor CI-976 binds inside the catalytic chamber and blocks the accessibility of the active site residues H460, N421 and W420. Our results pave the way for future mechanistic study and rational drug design targeting hSOAT1 and other mammalian MBOAT family members.

Reviews - 6l48 mentioned but not cited (2)



Reviews citing this publication (10)

  1. Update and nomenclature proposal for mammalian lysophospholipid acyltransferases, which create membrane phospholipid diversity. Valentine WJ, Yanagida K, Kawana H, Kono N, Noda NN, Aoki J, Shindou H. J Biol Chem 298 101470 (2022)
  2. Lipid droplet biogenesis and functions in health and disease. Zadoorian A, Du X, Yang H. Nat Rev Endocrinol 19 443-459 (2023)
  3. Lipid Metabolism in Glioblastoma: From De Novo Synthesis to Storage. Kou Y, Geng F, Guo D. Biomedicines 10 1943 (2022)
  4. An overview of ghrelin O-acyltransferase inhibitors: a literature and patent review for 2010-2019. Moose JE, Leets KA, Mate NA, Chisholm JD, Hougland JL. Expert Opin Ther Pat 30 581-593 (2020)
  5. Metabolites of Marine Sediment-Derived Fungi: Actual Trends of Biological Activity Studies. Yurchenko AN, Girich EV, Yurchenko EA. Mar Drugs 19 88 (2021)
  6. Mechanistic roles of mutant p53 governing lipid metabolism. Loughran RM, Emerling BM. Adv Biol Regul 83 100839 (2022)
  7. Structural enzymology of cholesterol biosynthesis and storage. Long T, Debler EW, Li X. Curr Opin Struct Biol 74 102369 (2022)
  8. Metabolic reprogramming in colorectal cancer: regulatory networks and therapy. Zhang J, Zou S, Fang L. Cell Biosci 13 25 (2023)
  9. Callyspongia spp.: Secondary Metabolites, Pharmacological Activities, and Mechanisms. Hadisaputri YE, Nurhaniefah AA, Sukmara S, Zuhrotun A, Hendriani R, Sopyan I. Metabolites 13 217 (2023)
  10. Targeting sterol-O-acyltransferase 1 to disrupt cholesterol metabolism for cancer therapy. Tu T, Zhang H, Xu H. Front Oncol 13 1197502 (2023)

Articles citing this publication (24)

  1. Substrate and product complexes reveal mechanisms of Hedgehog acylation by HHAT. Jiang Y, Benz TL, Long SB. Science 372 1215-1219 (2021)
  2. The structural basis for the phospholipid remodeling by lysophosphatidylcholine acyltransferase 3. Zhang Q, Yao D, Rao B, Jian L, Chen Y, Hu K, Xia Y, Li S, Shen Y, Qin A, Zhao J, Zhou L, Lei M, Jiang XC, Cao Y. Nat Commun 12 6869 (2021)
  3. Mechanisms and inhibition of Porcupine-mediated Wnt acylation. Liu Y, Qi X, Donnelly L, Elghobashi-Meinhardt N, Long T, Zhou RW, Sun Y, Wang B, Li X. Nature 607 816-822 (2022)
  4. Cholesterylation of Smoothened is a calcium-accelerated autoreaction involving an intramolecular ester intermediate. Hu A, Zhang JZ, Wang J, Li CC, Yuan M, Deng G, Lin ZC, Qiu ZP, Liu HY, Wang XW, Wei PC, He X, Zhao X, Qiu WW, Song BL. Cell Res 32 288-301 (2022)
  5. Molecular structures of human ACAT2 disclose mechanism for selective inhibition. Long T, Liu Y, Li X. Structure 29 1410-1418.e4 (2021)
  6. Structural mechanism of SGLT1 inhibitors. Niu Y, Cui W, Liu R, Wang S, Ke H, Lei X, Chen L. Nat Commun 13 6440 (2022)
  7. High-affinity SOAT1 ligands remodeled cholesterol metabolism program to inhibit tumor growth. Wang Z, Wang M, Zhang M, Xu K, Zhang X, Xie Y, Zhang Y, Chang C, Li X, Sun A, He F. BMC Med 20 292 (2022)
  8. Promoting anti-tumor immunity by targeting TMUB1 to modulate PD-L1 polyubiquitination and glycosylation. Shi C, Wang Y, Wu M, Chen Y, Liu F, Shen Z, Wang Y, Xie S, Shen Y, Sang L, Zhang Z, Gao Z, Yang L, Qu L, Yang Z, He X, Guo Y, Pan C, Che J, Ju H, Liu J, Cai Z, Yan Q, Yu L, Wang L, Dong X, Xu P, Shao J, Liu Y, Li X, Wang W, Zhou R, Zhou T, Lin A. Nat Commun 13 6951 (2022)
  9. Acute ACAT1/SOAT1 Blockade Increases MAM Cholesterol and Strengthens ER-Mitochondria Connectivity. Harned TC, Stan RV, Cao Z, Chakrabarti R, Higgs HN, Chang CCY, Chang TY. Int J Mol Sci 24 5525 (2023)
  10. In Silico-Based Design and In Vivo Evaluation of an Anthranilic Acid Derivative as a Multitarget Drug in a Diet-Induced Metabolic Syndrome Model. González-Álvarez H, Bravo-Jiménez A, Martínez-Arellanes M, Gamboa-Osorio GO, Chávez-Gutiérrez E, González-Hernández LA, Gallardo-Ignacio K, Quintana-Romero OJ, Ariza-Castolo A, Guerra-Araiza C, Martino-Roaro L, Meneses-Ruiz DM, Pinto-Almazán R, Loza-Mejía MA. Pharmaceuticals (Basel) 14 914 (2021)
  11. New Terpendole Congeners, Inhibitors of Sterol O-Acyltransferase, Produced by Volutella citrinella BF-0440. Nur EAA, Kobayashi K, Amagai A, Ohshiro T, Tomoda H. Molecules 25 E3079 (2020)
  12. Combined Lipidomics and Network Pharmacology Study of Protective Effects of Salvia miltiorrhiza against Blood Stasis Syndrome. Jin Y, Xie Z, Li S, Zeng X, Wang L, Hu P, Zhang H, Xiao X. Evid Based Complement Alternat Med 2021 5526778 (2021)
  13. Nanodisc scaffold peptide (NSPr) replaces detergent by reconstituting acyl-CoA:cholesterol acyltransferase 1 into peptidiscs. Neumann B, Chao K, Chang CCY, Chang TY. Arch Biochem Biophys 691 108518 (2020)
  14. Structures of human SGLT in the occluded state reveal conformational changes during sugar transport. Cui W, Niu Y, Sun Z, Liu R, Chen L. Nat Commun 14 2920 (2023)
  15. The structure of phosphatidylinositol remodeling MBOAT7 reveals its catalytic mechanism and enables inhibitor identification. Wang K, Lee CW, Sui X, Kim S, Wang S, Higgs AB, Baublis AJ, Voth GA, Liao M, Walther TC, Farese RV. Nat Commun 14 3533 (2023)
  16. Genomic adaptation of Ethiopian indigenous cattle to high altitude. Terefe E, Belay G, Han J, Hanotte O, Tijjani A. Front Genet 13 960234 (2022)
  17. Mechanism of action for small-molecule inhibitors of triacylglycerol synthesis. Sui X, Wang K, Song K, Xu C, Song J, Lee CW, Liao M, Farese RV, Walther TC. Nat Commun 14 3100 (2023)
  18. SOAT1 missense variant in two cats with sebaceous gland dysplasia. Kiener S, McMahill BG, Affolter VK, Welle M, Yager JA, Jagannathan V, Leeb T. Mol Genet Genomics 298 837-843 (2023)
  19. Cellular Uptake of a Fluorescent Ligand Reveals Ghrelin O-Acyltransferase Interacts with Extracellular Peptides and Exhibits Unexpected Localization for a Secretory Pathway Enzyme. Campaña MB, Davis TR, Novak SX, Cleverdon ER, Bates M, Krishnan N, Curtis ER, Childs MD, Pierce MR, Morales-Rodriguez Y, Sieburg MA, Hehnly H, Luyt LG, Hougland JL. ACS Chem Biol 18 1880-1890 (2023)
  20. Combined Computational-Biochemical Approach Offers an Accelerated Path to Membrane Protein Solubilization. Pierce MR, Ji J, Novak SX, Sieburg MA, Nangia S, Nangia S, Hougland JL. J Chem Inf Model 63 7159-7170 (2023)
  21. DNA methyltransferase 1 deficiency improves macrophage motility and wound healing by ameliorating cholesterol accumulation. Zhao C, Yang Q, Tang R, Li W, Wang J, Yang F, Zhao J, Zhu J, Pang W, Li N, Zhang X, Tian XY, Yao W, Zhou J. NPJ Regen Med 8 29 (2023)
  22. Mechanism of D-alanine transfer to teichoic acids shows how bacteria acylate cell envelope polymers. Schultz BJ, Snow ED, Walker S. Nat Microbiol 8 1318-1329 (2023)
  23. Reversible translocation of acyl-CoA:cholesterol acyltransferase (ACAT) between the endoplasmic reticulum and vesicular structures. Schiffmann A, Ahlswede L, Gimpl G. Front Mol Biosci 10 1258799 (2023)
  24. Structure of human phagocyte NADPH oxidase in the activated state. Liu X, Shi Y, Liu R, Song K, Chen L. Nature 627 189-195 (2024)